In her most recent role, Dr Milena worked on the implementation of the deliberatives of the São Paulo State Government Pharmaceutical Assistance Coordination. Her expertise also extends to the preparation of technical and scientific reports, literature reviews, data analysis, and scientific communication, both oral and written.ĭr Milena has served as a Clinical Pharmacist, providing expert supervision and guidance to teams during the challenging times of the COVID-19 pandemic, particularly in the ICUs of two reference hospitals for patient hospitalization. With a decade-long career as a researcher, Dr Milena has amassed extensive experience in conducting research projects in microbiology, analytical toxicology, and clinical pharmacokinetics. “Science can be translated, and it is essential that everyone has access to quality information to make informed decisions” – Dr Milena Oliveira, PhD. Bachelor in Biochemical Pharmacy, University of São Paulo, Brazil, 2013. University College London (UCL) – Semester of remote collaboration in the areas of Pharmacometrics and Population Pharmacokinetics, 2018. PhD in Sciences, University of São Paulo, Brazil, 2019. She writes and reviews content on these topics. She has experience in microbiology, analytical toxicology, and clinical pharmacokinetics. Serotonin–norepinephrine–dopamine reuptake inhibitors (SNDRI)ĭr Milena Locci de Oliveira is a Pharmacist and Doctor of Philosophy in Sciences from the University of São Paulo (USP). Serotonin–norepinephrine reuptake inhibitors (SNRIs)

Serotonin antagonist and reuptake inhibitors (SARIs) Selective serotonin reuptake inhibitors (SSRIs)

Norepinephrine–dopamine reuptake inhibitors (NDRIs) Norepinephrine–dopamine disinhibitors (NDDIs) Norepinephrine reuptake inhibitors (NRI, NERI) Going off antidepressants.Noradrenergic and specific serotonergic antidepressants (NaSSAs)

Changes in markers of brain serotonin activity in response to chronic exercise in senior men. Anxiety and depression are better correlates of Parkinson's disease quality of life than apathy. Kaplan & Sadock’s Concise Textbook of Clinical Psychiatry (4th edition). Treatment effectiveness and tolerability outcomes that are most important to individuals with bipolar and unipolar depression. Long-term antidepressant use: Patient perspectives of benefits and adverse effects. Adverse effects of antidepressants reported by a large international cohort: Emotional blunting, suicidality, and withdrawal effects. Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant. Patel K, Allen S, Haque MN, Angelescu I, Baumeister D, Tracy DK. Emotional blunting with antidepressant treatments: A survey among depressed patients. Goodwin GM, Price J, De Bodinat C, Laredo J. Emotional blunting in patients with major depressive disorder: A brief non-systematic review of current research. Emotional blunting in patients with depression. Cronquist Christensen M, Ren H, Fagiolini A.

Lexapro sleeplessness